PLSM
Pulsenmore Ltd.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Jun 25 Pulsenmore priced a $7.5M private placement of 1,562,500 ordinary sh…
- X Jul 15 Short interest jumps 412.7% to 322.5K
- X Jul 31 Short interest falls 94.9% to 16.4K
- X Aug 14 Short interest falls 46.4% to 8.8K
- X Aug 31 Short interest jumps 68.6% to 14.9K
- R Sep 8 Pulsenmore announced CE European registration (MDR) for its second p…
- X Sep 15 Short interest jumps 42.5% to 21.2K
- X Sep 30 Short interest falls 63.5% to 7.7K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 0 trimmed or exited.
- Short sellersCOVERING
Short interest −63.5% to 7.7K shares. 1.0 days to cover, ≈0.1% of shares.
- TrendDOWNTREND
21% below its 50-day average. New closing low $1.76 on Oct 20.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $111.6K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 19, 2026 | Woods David Chief Commercial Officer | AWARD | 6,886 sh |
| Oct 14, 2026 | Guz-Lavi Racheli Director | EXERCISE | $1.5K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026SecBot reports
13 filings · 1 bullish · 2 bearish · 1 mixed · 9 neutral- NEUTRAL 6-KOct 13, 2026
Pulsenmore appointed med-tech veteran David Woods as Chief Commercial Officer and expanded its…
Monitor for first U.S. commercial revenue disclosures in upcoming quarterly filings and any updates on RHTP-related contracts. The appointment of a seasoned CCO signals execution focus, but revenue…
- NEUTRAL SC 13GOct 8, 2026
Analysis based on filing metadata only — document content was unavailable. A Schedule 13G was…
Without the filing document, the investor identity and stake size are unknown. Monitor for a subsequent SC 13G amendment or a potential conversion to SC 13D if the filer later becomes active. The…
- NEUTRAL 6-KSep 17, 2026
Pulsenmore announced MHRA registration for its Pulsenmore FC home ultrasound system, enabling…
Monitor for commercial partnership announcements or initial sales data from the UK market in upcoming quarters. The lack of disclosed revenue guidance or distribution agreements limits near-term…
- BULLISH 6-KSep 8, 2026
Pulsenmore announced CE European registration (MDR) for its second product, Pulsenmore FC, a home…
The CE registration is a clear product-level catalyst that expands Pulsenmore's addressable market into European fertility clinics, but with no revenue guidance or commercial terms disclosed, the…
All PLSM filing & press-release reports (13)
- 6-K reportOct 13, 2026
- SC 13G reportOct 8, 2026
- 6-K reportSep 17, 2026
- 6-K reportSep 8, 2026
- EFFECT reportSep 2, 2026
- 6-K reportAug 31, 2026
- 6-K reportAug 19, 2026
- 6-K reportAug 17, 2026
- 6-K reportJul 13, 2026
- EFFECT reportJul 13, 2026
- F-1 reportJul 2, 2026
- 6-K reportJun 25, 2026
- 6-K reportMay 7, 2026